Nalbuphine Hydrochloride

盐酸纳布啡

Report date: 2025/05/26 17:52:26
NME

Base Information

Drug NameNalbuphine Hydrochloride
Drug Alias Name盐酸环丁甲羟氢吗啡nalbufina纳布啡盐酸盐水合物Nalbuphinum环丁甲羟氢吗啡 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors agonists
TargetsOpioid receptors
Therapy Area/IndicationsPainPain, PostoperativePostoperative Complications +[5] 
Global Approved IndicationsPainAnesthesia
Approved Indications in ChinaPain
Original Approved Country/TerritoryUnited States
Original Approved Date1979/05/15
Country/TerritoryUnited StatesEgyptMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEndo International Plc
China Registration ClassN/A

Develop Information

Active CompaniesYichang Humanwell Pharmaceutical Co LtdAin Shams UniversityYangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co Ltd
Inactive CompaniesPH Health LtdAssiut University
Active IndicationsPainPain, PostoperativeEmergence Delirium
Inactive IndicationsPostoperative ComplicationsAnesthesia

Other Information

ATC CodeN02AF02
Related LinksWikipediaDrugBankKEGG